Cognitrion™ is an AI-assisted cognitive assessment platform for aphasia. Built for Indian clinics. Supervised by clinicians at every step.
Millions of stroke survivors are left without timely, accurate cognitive assessment — because the system was never built for the scale of need.
India records approximately 1.2–1.8 million new strokes every year. Aphasia affects 21–38% of stroke survivors — leaving an estimated 2 million Indians living with aphasia, most without formal assessment.
Source: Aphasia & Stroke Association of India; Global Burden of Disease Study 2016 (PMC8821978)
India’s speech-language pathology workforce is severely understaffed. Demand for clinical aphasia services is estimated to outpace practitioner supply by more than 10:1, with rural and semi-urban patients having virtually no access to formal assessment.
Source: Indian Speech & Hearing Association (ISHA); Rehabilitation Council of India (RCI)
The WAB-R takes 45–90 minutes to administer, with additional clinician time for scoring and report generation — typically 1–2 hours total per session. Scoring is manual, reports are inconsistent, and longitudinal tracking across sessions rarely happens at scale.
Source: Pearson Assessments, WAB-R Technical Manual; Strokengine.ca
Every design decision starts with patient safety and clinician authority. The AI surfaces evidence; clinicians make every call.
The system adjusts assessment difficulty in real time based on patient responses, fatigue indicators, and clinical context — ensuring accurate evaluation without patient distress.
Built-in speech recognition for Hindi, Marathi, Tamil, and English. Culturally appropriate stimulus materials and assessment protocols for Indian clinical contexts.
Low-confidence results pause for mandatory clinician review. Override with rationale. Every clinician decision is preserved alongside the AI recommendation for complete transparency.
Tamper-evident audit trail for every clinical decision. Full compliance logging with immutable records. Designed for HIPAA-aligned data protection from the ground up.
A structured assessment workflow. Every step logged, audited, and clinician-reviewable.
Capture demographics, consent, and presenting symptoms. Linguistic and clinical context established from the first interaction.
Standard aphasia assessment tasks — including picture description, repetition, and naming — captured through speech recognition and clinician observation.
Aphasia classification, severity assessment, and evidence-based therapy recommendations in a clinician-reviewed report.
You remain the sole decision authority. Cognitrion surfaces clinical evidence; you make the calls.
AI classifications below the confidence threshold are flagged immediately. Review cases sorted by clinical urgency — the session pauses until you approve, override, or defer.
Transcript, extracted features, assessment scores, confidence level, and source citations — all in one review panel. Nothing hidden, nothing summarised away.
Disagree with the AI? Select the correct classification and enter your clinical rationale. The original AI recommendation is preserved alongside your decision for full audit history.
Syndrome classification, therapy plan, severity assessment, and session summary in a signed PDF report. Every report carries a mandatory AI advisory disclaimer.
Every protocol in Cognitrion™ was designed with a neuropsychologist in the room — not retrofitted after engineering.
Clinical Design Lead · Practicing Researcher
MSc Applied Neuropsychology, University of Bristol, UK
MSc Psychological Research Methods, University of Stirling, UK
Designed all assessment protocols, language adaptations, and clinical report formats. Ensures every AI output is grounded in established neuropsychological practice.
Technology Lead · Agentic AI Specialist
MCA (Master of Computer Applications)
PMP® · CSM® · ISTQB
Director, AI-Led Engineering · 25+ years in enterprise technology
Built the deterministic-core, human-governed AI framework. HIPAA-aligned architecture, full audit chain, and safety invariants baked in from day one.
Indian Patent Application No. 202521091684 · Filed 24 Sep 2025 · Activense Holistic Solutions Pvt Ltd
A de-identified sample showing aphasia severity classification, domain scores, confidence levels, and recommended intervention pathway.
Request Sample Report →We’ll send a de-identified PDF within 24 hours · No commitment required
No. Cognitrion™ is a supervised clinical tool. The clinician is present throughout and signs off on every report. Zero unsupervised diagnoses are ever generated.
Yes. All data is encrypted at rest and in transit. The system is architecturally aligned with HIPAA (45 CFR §164.312). A full compliance audit is completed before clinical deployment at your site.
A 4-week supervised trial at your site — we configure the language protocol, train your team (approx. 2 hrs), and provide weekly review calls with Manas Bhoskar. No upfront cost for pilot sites.
PDF reports can be attached to any EMR. Native EMR integration (HL7 FHIR) is on the roadmap and will be scoped during pilot onboarding based on your system.
Join our Q2 2026 pilot. We’ll configure Cognitrion™ for your site’s language needs and walk you through a live patient assessment session.
See Cognitrion in action. We’ll walk you through a complete patient assessment — from intake to signed clinical report.
Request Clinical Demo →info@cognitrion.ai · No commitment required